The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt

BACKGROUND: A significant proportion of patients with epilepsy have an unknown etiology and lack effective targeted therapeutic drugs. Patent Foramen Ovale (PFO) induces hypoxia and microembolism, leading to cerebral neurological dysfunction and increased epilepsy risk. This study aims to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuming, Ji, Hua, Li, Yusha, Tang, Lei, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373383/
https://www.ncbi.nlm.nih.gov/pubmed/37501155
http://dx.doi.org/10.1186/s12883-023-03317-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373383/
https://www.ncbi.nlm.nih.gov/pubmed/37501155
http://dx.doi.org/10.1186/s12883-023-03317-0

Ejemplares similares